Traduction de «global dementia » (Anglais → Français) :

Global Dementia Legacy Event

vascular dementia | arteriosclerotic dementia | multidefect dementia | multiinfarct dementia | multi-infarct dementia

AIDS dementia complex [ AIDS-related dementia complex | HIV dementia | HIV encephalopathy | HIV-1-associated cognitive motor complex | HIV-associated cognitive motor complex | acquired-immune deficiency syndrome dementia complex | HIV-1 cognitive and motor complex ]

Global action against dementia

AIDS dementia complex | AIDS-related dementia | HIV dementia syndrome | HIV encephalopathy | HIV-associated dementia | ADC [Abbr.] | ARD [Abbr.]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

dementia due to head trauma | posttraumatic dementia

dementia with Lewy bodies | Lewy body dementia

frontal lobe dementia | frontotemporal dementia

WELCOMES the Call for Action signed by participants at the first WHO Ministerial Conference on Global Action Against Dementia in Geneva on 17 March 2015, which underlined governments' primary role and responsibility in responding to the challenge of dementia and emphasised the need for multi-sectoral and coordinated action at global and national level, aimed notably at advancing prevention, risk reduction, diagnosis and treatment of dementia

In 2010, the global cost of dementia stood at around $604 billion, or 1 per cent of global GDP.

The bill calls for the office to develop a national plan to address dementia in conjunction with the provincial and territorial health departments with special goals and an annual report to Parliament; take necessary measures to accelerate the discovery and development of treatments that would prevent, halt or reverse the course of dementia; encourage greater investment in all areas of dementia research; coordinate with international bodies to continue the fight against dementia globally and to build on Canada's existing contributi ...[+++]ons in this field; assess and disseminate best practices; improving the quality of life of people with dementia and their caregivers; and make recommendations to support and strengthen Canada's dementia care workforce.

It is estimated that over 35 million people suffer from dementia globally, and this number could double every 20 years. In Europe, 9.9 million people suffer from dementia and many of them have Alzheimer’s disease.